Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

System for introducing HIV nucleic acid vaccine through constant-voltage electric pulse

A nucleic acid vaccine and electric pulse technology, applied in the system field of nucleic acid vaccine introduction into target tissue, can solve the problems of influence, low efficiency of anti-AIDS nucleic acid vaccine introduction, etc., and achieve the effect of enhancing treatment effect, preventing and treating AIDS

Inactive Publication Date: 2017-07-07
SHANGHAI TERESA BIO TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, the introduction efficiency of the current anti-AIDS nucleic acid vaccine is low, which objectively affects its function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • System for introducing HIV nucleic acid vaccine through constant-voltage electric pulse
  • System for introducing HIV nucleic acid vaccine through constant-voltage electric pulse
  • System for introducing HIV nucleic acid vaccine through constant-voltage electric pulse

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] The above-mentioned features and advantages of the present invention can be better understood after reading the detailed description of the embodiments of the present disclosure in conjunction with the following drawings. In the drawings, components are not necessarily drawn to scale, and components with similar related properties or characteristics may have the same or similar reference numerals.

[0032] figure 1 The principle of a preferred embodiment of the system for introducing AIDS nucleic acid vaccine of the present invention is shown, please refer to figure 1 . The system of this embodiment includes two parts: an electric pulse introduction device 10 and an injection device 20 . Wherein the injection device 2 may be a syringe injector. The electrical pulse introduction device 10 includes: a power supply module 100 , a pulse setting and implementation module 101 , a pulse generation module 102 , a microcontroller 106 and a load 107 . Preferably, the electric...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a system for introducing an HIV nucleic acid vaccine through a constant-voltage electric pulse. With the system, a nucleic acid vaccine for preventing and treating AIDS can be introduced to cells. Therefore, the efficiency of nucleic acid vaccine introduction into the body is improved, and the treatment effect is enhanced. According to the technical scheme, first, an HIV nucleic acid vaccine is injected using an injection device, and then, an electric pulse introduction device emits a low-frequency electric pulse to stimulate the human muscle and other target tissues to introduce the molecules of the nucleic acid vaccine for preventing and treating AIDS into cells. The treatment effect is enhanced. Moreover, the introduction effect of the AIDS vaccine is adjusted through design of waveform parameters and load electrodes, and an effect of AIDS prevention and treatment with high efficiency and low dosage is achieved.

Description

technical field [0001] The invention relates to a vaccine introduction system, in particular to a system for introducing nucleic acid vaccines for preventing and treating AIDS into target tissues by using electroporation technology. Background technique [0002] As early as 1981, the world's first AIDS patient was discovered. The continuous mutation of the virus, the diversity of genes, and the high cost of vaccine development have affected the development and application of AIDS vaccines. Improving efficiency and reducing costs have become the main hot spots. Vaccines are divided into preventive vaccines and therapeutic vaccines. The role of preventive vaccines is to prevent infection with viruses, while the role of therapeutic vaccines is to induce the human immune system to resist the damage caused by viruses to the human body, or to enhance the immune system’s resistance to viruses. people who have been infected with the virus. From 1985 to around 1990, the number of H...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61N1/32A61M5/178
CPCA61N1/325A61M5/178A61M2202/04A61M2202/0007
Inventor 陈车生彭华磊陈丽晔杨峰
Owner SHANGHAI TERESA BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com